Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT05239312 Not yet recruiting - Clinical trials for Prosthetic Joint Infection

Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital

Start date: March 2022
Phase:
Study type: Observational

1. Setting of antibiogram in orthopedic department 2. Evaluate the production of biofilm in bacteria isolated from specimens phenotypically and genotypically.

NCT ID: NCT05234515 Completed - Clinical trials for Surgical Site Infection

Bacteriology of sUrGical Site INfection Following Surgery for Intestinal Failure

BUGS-IN-IF
Start date: January 14, 2022
Phase:
Study type: Observational

This is a prospective observational study of patients undergoing planned surgery for intestinal failure. The aims of the study are: - To prospectively characterise preoperative bacterial populations amongst patients undergoing surgery for intestinal failure - To examine the relationship between preoperative bacteriology and surgical site infection (SSI) in this patient group - To investigate the effect of surgery and surgical site infection on generic and wound specific quality of life measures

NCT ID: NCT05234385 Completed - Clinical trials for Sternoclavicular Joint Infection

Functional Outcome Following Surgical Treatment of Patients With Sternoclavicular Joint Infection

SCJ Infection
Start date: January 2, 2022
Phase:
Study type: Observational

The Sternoclavicular joints (SCJ) represents an important factor in stability of shoulder joint. Its influence and its function is important for the functionality of the shoulder. SCJ infection is a rare condition and remains often mistreated and potentially life threatening. This study is to assess the cases treated at the University Hospital Basel with a surgical approach of extended resection of the SCJ. One prospective follow-up visit inclusive one physical examination per patient will be performed to evaluate the long-term functional results of arm, shoulder, hand function with the QuickDASH questionnaire.

NCT ID: NCT05234359 Completed - Covid19 Clinical Trials

The CHILD Cohort COVID-19 Add-On Study

Start date: October 6, 2020
Phase:
Study type: Observational [Patient Registry]

The objective of this study is to determine the prevalence and transmission of SARS-CoV-2 infection among Canadian children and parents in the CHILD cohort, identify predictors of infection susceptibility and severity, and understand the health and psychosocial impacts of the COVID-19 pandemic on CHILD families.

NCT ID: NCT05229926 Completed - Infectious Disease Clinical Trials

Implementation of CareCube Negative Pressure Isolation Units

CareCube
Start date: March 27, 2021
Phase:
Study type: Observational

Pilot study to provide a descriptive analysis of the real-world feasibility of using a CareCube for COVID-19 patients in a high-volume tertiary care hospital.

NCT ID: NCT05229276 Completed - Clinical trials for Coronary Artery Disease

Efficacy of Sternum Guard in Post Cardiac Surgery Patient

Start date: May 17, 2020
Phase: N/A
Study type: Interventional

This is a single-center, single-blind, randomized parallel superiority trial comparing two groups; Sternum GuardTM as the treatment arm and Bone Wax as the active control group. Both investigated modalities are materials used during sternotomy for covering the sewn sternal edge. The primary outcomes of this study comprised of four parameters; namely surgical site infection (superficial or deep infection), sternal dehiscence, hemostatic effect, and surgeon's satisfaction rate. The first three primary outcomes were assessed during the operation, at the end of the hospital stay, 14 days, and 30-days postoperative.

NCT ID: NCT05228132 Terminated - Clinical trials for End Stage Renal Disease

The Pristine Post-Market Study

Start date: May 16, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, single-arm study designed to assess the safety and performance of the Pristineā„¢ Long-Term Hemodialysis Catheter.

NCT ID: NCT05226949 Completed - Neonatal Sepsis Clinical Trials

Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Start date: January 1, 2022
Phase:
Study type: Observational

This study seeks to identify and test host RNA expression profiles in context to protein biomarkers in dried blood spot samples as novel diagnostic markers of neonatal herpes simplex virus infection and to improve the understanding of the pathogenesis of the disease.

NCT ID: NCT05226819 Recruiting - Clinical trials for Helicobacter Pylori Infection

Influencing Factors of Helicobacter Pylori Infection and Eradication Failure

Start date: February 6, 2022
Phase: N/A
Study type: Interventional

Helicobacter pylori (H. pylori) is closely related to the occurrence of gastric cancer and other diseases, the discovery and eradication of H. pylori infection has great significance to the prevention and treatment of related diseases. At the same time,understanding the influencing factors of H. pylori infection and eradication failure in the population can provide a scientific basis for the formulation of local H. pylori prevention and control strategies. So, the investigators intend to analyze the factors related to H. pylori infection and eradication failure in the outpatients of gastroenterology clinics in Xi'an, China.

NCT ID: NCT05226403 Completed - Covid19 Clinical Trials

COVID-19 : Pulmonary Ultrasound in Primary Care

ECHOVID-MG
Start date: July 1, 2020
Phase:
Study type: Observational

COVID-19 infection are characterized by fever and signs of acute respiratory infection. A worsening of respiratory symptoms that can lead to respiratory failure. The decompensation can then be brutal and require rapid recourse to respiratory assistance. The contribution of clinical examination (auscultation and monitoring of oxygen saturation in particular) remains unsatisfactory in predicting an unfavorable course. The interest of pulmonary ultrasound is known in the management of pulmonary infections. However, estimating the severity of lung damage at an early stage could be of great help in monitoring and caring for patients. Ultrasound could meet this need in general practice, the chest scanner is often unavailable in these situations. Ultrasound signs are associated with severe forms. The contribution of pulmonary ultrasound seems particularly interesting in the context of the reassessment of patients during the worsening phase of symptoms (D5-D10). Estimate the prevalence of ultrasound signs in patients with an acute respiratory infection suspected or confirmed to be COVID-19, at the time of the worsening phase (between D5 and D10 of the onset of symptoms). The prevalence of ultrasound lung lesions under COVID-19 may be essential to consider the development of the ultrasound tool in primary care. Indeed, if the contribution of ultrasound is now recognized in intensive care or emergency, its place in general medicine still raises questions.